Monte Rosa Therapeutics, Inc. Interim clinical data from GFORCE-1 trial of NEK7-directed MGD MRT-8102 demonstrated profound CRP reductions in subjects ...
TOLREMO Competitors or Alternatives
TOLREMO's top competitors include Cellestia, Nouscom and TargImmune Therapeutics.
TOLREMO VS Cellestia
Cellestia is TOLREMO's #1 rival. Cellestia is a Private company that was founded in Basel, Basel-Country in 2014. Like TOLREMO, Cellestia also works within the Biotechnology field. Cellestia has 5 more employees vs. TOLREMO.
TOLREMO VS Nouscom
Nouscom is perceived as one of TOLREMO's biggest rivals. Nouscom was founded in 2015, and is headquartered in Basel, Basel-Country. Like TOLREMO, Nouscom also operates in the Biotechnology sector. Nouscom generates $6.2M more revenue vs. TOLREMO.
TOLREMO VS TargImmune Therapeutics
TargImmune Therapeutics is a top competitor of TOLREMO. TargImmune Therapeutics is a Private company that was founded in 2016 in Basel, Basel-City. Like TOLREMO, TargImmune Therapeutics also operates in the Biotechnology space. Compared to TOLREMO, TargImmune Therapeutics has 15 more employees.
Looking for similar companies to TOLREMO?
Similar Companies
Biotechnology companies in Basel-City
See 33 companies
Companies in Basel-City with employees in 1-25 rangeSee 46 companies
Biotechnology companies in BaselSee 53 companies
Pharmaceuticals & Biotechnology companies in Basel-CitySee 55 companies
Companies in Basel with employees in 1-25 rangeSee 64 companies
Companies in Basel-City with revenue in $100K-5.0M rangeSee 70 companies
Pharmaceuticals & Biotechnology companies in BaselSee 88 companies
Companies in Basel with revenue in $100K-5.0M rangeSee 102 companies
Biotechnology companies in SwitzerlandSee 408 companies
Trending News for TOLREMO and TOLREMO's Competitors
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting
REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 2026 Annual Meeting PR Newswire ROCKVILLE, Md., May 7, 2026 ROCKVILLE,...
Monte Rosa Therapeutics (GLUE) delivered earnings and revenue surprises of -58.84% and -80.59%, respectively, for the quarter ended March 2026. Do the ...
Frequently Asked Questions about TOLREMO
Who are TOLREMO's top competitors?
TOLREMO's top 3 competitors are Cellestia, Nouscom, TargImmune Therapeutics.Who is similar to TOLREMO?
Cellestia is the most similar to TOLREMO. Nouscom and TargImmune Therapeutics are also similar to TOLREMO.
Are TOLREMO and Cellestia competitors?
Yes, Cellestia is one of TOLREMO’s top competitors.